US4291028A
(en)
*
|
1977-12-30 |
1981-09-22 |
Nichols Vorys |
Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
|
US4390531A
(en)
*
|
1981-08-10 |
1983-06-28 |
Syntex Pharmaceuticals International Ltd. |
Method of contraception using peak progestogen dosage
|
US5010070A
(en)
*
|
1987-06-15 |
1991-04-23 |
Warner-Lambert Company |
Graduated estrogen contraceptive
|
US5116865A
(en)
*
|
1990-09-05 |
1992-05-26 |
Peters Richard H |
15,16-seco-19-nor progestins
|
IE71202B1
(en)
*
|
1990-12-17 |
1997-02-12 |
Akzo Nv |
Progestagen-only contraceptive
|
US5433219A
(en)
*
|
1992-09-23 |
1995-07-18 |
Spery; Nanette S. |
Receptive condom assembly
|
WO1999051214A2
(fr)
*
|
1998-04-07 |
1999-10-14 |
Akzo Nobel N.V. |
Kit contraceptif base uniquement sur la progestogene
|
WO2000009136A1
(fr)
*
|
1998-08-11 |
2000-02-24 |
Akzo Nobel N.V. |
Kit contraceptif base uniquement sur le progestogene et permettant un controle efficace du cycle
|
US20050038006A1
(en)
*
|
1998-12-23 |
2005-02-17 |
Shangold Gary A. |
Triphasic oral contraceptive
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US7989436B2
(en)
*
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
EP1622623A4
(fr)
*
|
2003-04-11 |
2009-03-18 |
Barr Lab Inc |
Procede d'administration d'oestrogenes et de progestatifs
|
DE10330213A1
(de)
*
|
2003-07-03 |
2005-02-17 |
Ludwig Prof. Dr.med. Neyses |
Verwendung von Inhibitoren der Plasmamembran-Calcium-Atpase (PMCA) zur Hemmung der Spermienmobilität
|
DE102004019743B4
(de)
*
|
2004-04-20 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
|
CA2601773A1
(fr)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
|
US8153616B2
(en)
*
|
2005-10-17 |
2012-04-10 |
Bayer Pharma Aktiengesellschaft |
Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
|
US20070254858A1
(en)
*
|
2006-04-27 |
2007-11-01 |
Cronk Peter J |
Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
|
US20070254025A1
(en)
*
|
2006-04-27 |
2007-11-01 |
Cronk Peter J |
Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
|
EP1930010A1
(fr)
*
|
2006-10-20 |
2008-06-11 |
Bayer Schering Pharma Aktiengesellschaft |
Utilisation de valvérate d'estradiol ou de 17ß-estradiol combiné à du dienogest pour traiter par voie orale la récupération et/ou l'augmentation de la libido féminine
|
DE102008036825A1
(de)
*
|
2008-08-05 |
2010-02-11 |
Aicuris Gmbh & Co. Kg |
Schwangerschaftsvermeidung durch Gestagene
|